SCHEMBL23965328

SCHEMBL23965328

c1ccc(-c2nc(-c3ccc(-c4cccc5ccccc45)cc3)nc(-c3cccc4c3-c3ccccc3C43c4ccccc4Sc4ccccc43)n2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
MAPT P10636 2/20 0.38
HPGD P15428 2/20 0.38
MAPK1 P28482 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HSD17B10 Q99714 2/20 0.38
TSHR P16473 2/20 0.38
ATM Q13315 2/20 0.38
TP53 P04637 1/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
TNF P01375 1/20 0.35
HDAC8 Q9BY41 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23965156 0.97 KDM4E (0.39) KDM4EALDH1A1MAPTHPGDMAPK1
SCHEMBL23965368 0.95 TSHR (0.38) KDM4EALDH1A1MAPTHPGDMAPK1
SCHEMBL22100210 0.95 MAPT (0.39) KDM4EALDH1A1MAPTHPGDMAPK1
SCHEMBL23965332 0.93 KDM4E (0.36) KDM4EALDH1A1MAPTHPGDMAPK1
SCHEMBL23965372 0.93 KDM4E (0.34) KDM4EALDH1A1MAPTHPGDMAPK1
SCHEMBL21151252 0.91 ALOX15 (0.35) KDM4EALDH1A1MAPTHPGDMAPK1
SCHEMBL22908169 0.91 ALOX15 (0.35) KDM4EALDH1A1MAPTHPGDMAPK1
SCHEMBL21151976 0.91 TSHR (0.36) KDM4EALDH1A1MAPTHPGDMAPK1
SCHEMBL22908022 0.90 CYP1A2 (0.34) HDAC8HDAC6CYP2C9CYP2C19CYP1A2
SCHEMBL21477886 0.89 ALOX15 (0.34) KDM4EALDH1A1MAPTHPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210336155-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2021-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210336155-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CCNL2, MCM6, CRY1 KDM4E 2468/4885ALDH1A1 2007/4885MAPT 3677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.